BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mohsen W, Williams AJ, Wark G, Sechi A, Koo JH, Xuan W, Bassan M, Ng W, Connor S. Prospective single-blinded single-center randomized controlled trial of Prep Kit-C and Moviprep: Does underlying inflammatory bowel disease impact tolerability and efficacy? World J Gastroenterol 2021; 27(11): 1090-1100 [PMID: 33776375 DOI: 10.3748/wjg.v27.i11.1090]
URL: https://www.wjgnet.com/1007-9327/full/v27/i11/1090.htm
Number Citing Articles
1
Anand Kumar, Vinayak Shenoy, Megan C. Buckley, Laura Durbin, James Mackey, Anjali Mone, Arun Swaminath. Endoscopic Disease Activity and Biologic Therapy Are Independent Predictors of Suboptimal Bowel Preparation in Patients with Inflammatory Bowel Disease Undergoing ColonoscopyDigestive Diseases and Sciences 2022;  doi: 10.1007/s10620-022-07530-8